Baidu
map
AUST NZ J OBSTET GYN 润色咨询

AUSTRALIAN & NEW ZEALAND JOURNAL OF OBSTETRICS & GYNAECOLOGY

出版年份：1961 年文章数：2152 投稿命中率： 开通期刊会员，数据随心看

出版周期：Bimonthly 自引率：11.2% 审稿周期： 开通期刊会员，数据随心看

前往期刊查询
期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索

期刊讨论

  1. [GetPortalCommentsPageByObjectIdResponse(id=848108, encodeId=926f848108ab, content=审稿速度:3.0<br>经验分享：相较而言还是不错的一个期刊，除了if没有特别高以外 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Nov 09 10:35:25 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087621, encodeId=a0eb108e621d1, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087622, encodeId=0941108e6228e, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079020, encodeId=5abe10e9020b3, content=想问一下大家为什么注册不了账户啊 邮箱无法填入 大家都是怎么解决的啊 谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/4d9b1e23c2814b27bc504303cfc13690/e7f89e62874d4f99ad9ccedb7217384e.jpeg, createdBy=33e75274483, createdName=Zurine, createdTime=Sat Dec 11 11:27:32 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601328, encodeId=ad15601328d1, content=没人分享经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94551317185, createdName=sfwq007, createdTime=Thu Jun 04 09:34:20 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578827, encodeId=03915e8827ee, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2018-11-09 ms9285292773773234

    审稿速度:3.0
    经验分享：相较而言还是不错的一个期刊，除了if没有特别高以外

    2

    展开2条回复
  2. [GetPortalCommentsPageByObjectIdResponse(id=848108, encodeId=926f848108ab, content=审稿速度:3.0<br>经验分享：相较而言还是不错的一个期刊，除了if没有特别高以外 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Nov 09 10:35:25 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087621, encodeId=a0eb108e621d1, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087622, encodeId=0941108e6228e, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079020, encodeId=5abe10e9020b3, content=想问一下大家为什么注册不了账户啊 邮箱无法填入 大家都是怎么解决的啊 谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/4d9b1e23c2814b27bc504303cfc13690/e7f89e62874d4f99ad9ccedb7217384e.jpeg, createdBy=33e75274483, createdName=Zurine, createdTime=Sat Dec 11 11:27:32 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601328, encodeId=ad15601328d1, content=没人分享经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94551317185, createdName=sfwq007, createdTime=Thu Jun 04 09:34:20 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578827, encodeId=03915e8827ee, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-12-29 MS68862005

    文章的局限性是什么？

    1

    展开1条回复
  3. [GetPortalCommentsPageByObjectIdResponse(id=848108, encodeId=926f848108ab, content=审稿速度:3.0<br>经验分享：相较而言还是不错的一个期刊，除了if没有特别高以外 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Nov 09 10:35:25 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087621, encodeId=a0eb108e621d1, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087622, encodeId=0941108e6228e, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079020, encodeId=5abe10e9020b3, content=想问一下大家为什么注册不了账户啊 邮箱无法填入 大家都是怎么解决的啊 谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/4d9b1e23c2814b27bc504303cfc13690/e7f89e62874d4f99ad9ccedb7217384e.jpeg, createdBy=33e75274483, createdName=Zurine, createdTime=Sat Dec 11 11:27:32 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601328, encodeId=ad15601328d1, content=没人分享经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94551317185, createdName=sfwq007, createdTime=Thu Jun 04 09:34:20 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578827, encodeId=03915e8827ee, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-12-29 小动量

    是否需要在讨论中说明文章局限性？

    1

    展开1条回复
  4. [GetPortalCommentsPageByObjectIdResponse(id=848108, encodeId=926f848108ab, content=审稿速度:3.0<br>经验分享：相较而言还是不错的一个期刊，除了if没有特别高以外 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Nov 09 10:35:25 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087621, encodeId=a0eb108e621d1, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087622, encodeId=0941108e6228e, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079020, encodeId=5abe10e9020b3, content=想问一下大家为什么注册不了账户啊 邮箱无法填入 大家都是怎么解决的啊 谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/4d9b1e23c2814b27bc504303cfc13690/e7f89e62874d4f99ad9ccedb7217384e.jpeg, createdBy=33e75274483, createdName=Zurine, createdTime=Sat Dec 11 11:27:32 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601328, encodeId=ad15601328d1, content=没人分享经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94551317185, createdName=sfwq007, createdTime=Thu Jun 04 09:34:20 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578827, encodeId=03915e8827ee, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2021-12-11 Zurine

    想问一下大家为什么注册不了账户啊 邮箱无法填入 大家都是怎么解决的啊 谢谢谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=848108, encodeId=926f848108ab, content=审稿速度:3.0<br>经验分享：相较而言还是不错的一个期刊，除了if没有特别高以外 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Nov 09 10:35:25 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087621, encodeId=a0eb108e621d1, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087622, encodeId=0941108e6228e, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079020, encodeId=5abe10e9020b3, content=想问一下大家为什么注册不了账户啊 邮箱无法填入 大家都是怎么解决的啊 谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/4d9b1e23c2814b27bc504303cfc13690/e7f89e62874d4f99ad9ccedb7217384e.jpeg, createdBy=33e75274483, createdName=Zurine, createdTime=Sat Dec 11 11:27:32 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601328, encodeId=ad15601328d1, content=没人分享经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94551317185, createdName=sfwq007, createdTime=Thu Jun 04 09:34:20 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578827, encodeId=03915e8827ee, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2020-06-04 sfwq007

    没人分享经验吗？

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=848108, encodeId=926f848108ab, content=审稿速度:3.0<br>经验分享：相较而言还是不错的一个期刊，除了if没有特别高以外 , beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=174, replyNumber=2, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=0dc95414078, createdName=ms9285292773773234, createdTime=Fri Nov 09 10:35:25 CST 2018, time=2018-11-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087621, encodeId=a0eb108e621d1, content=文章的局限性是什么？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=77, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=bb142989248, createdName=MS68862005, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1087622, encodeId=0941108e6228e, content=是否需要在讨论中说明文章局限性？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=78, replyNumber=1, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210512/e664bd00445a497ca6dfc89ec35b9206/0bfbc1258d9f4ec6aba6990cbd76f3e2.jpg, createdBy=e9d85497901, createdName=小动量, createdTime=Wed Dec 29 14:52:47 CST 2021, time=2021-12-29, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1079020, encodeId=5abe10e9020b3, content=想问一下大家为什么注册不了账户啊 邮箱无法填入 大家都是怎么解决的啊 谢谢谢谢, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=66, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210904/4d9b1e23c2814b27bc504303cfc13690/e7f89e62874d4f99ad9ccedb7217384e.jpeg, createdBy=33e75274483, createdName=Zurine, createdTime=Sat Dec 11 11:27:32 CST 2021, time=2021-12-11, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=601328, encodeId=ad15601328d1, content=没人分享经验吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=157, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=94551317185, createdName=sfwq007, createdTime=Thu Jun 04 09:34:20 CST 2020, time=2020-06-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=578827, encodeId=03915e8827ee, content=求经验求分享, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=206, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://cdnapi.center.medsci.cn/medsci/head/2019/10/21/e031c1d6c6115cbe1737b2149e602c1d.jpg, createdBy=3c105212218, createdName=147612bem32暂无昵称, createdTime=Fri Oct 25 00:00:00 CST 2019, time=2019-10-25, status=1, ipAttribution=)]
    2019-10-25 147612bem32暂无昵称

    求经验求分享

    0

共10条页码: 1/1页10条/页
分享您的投稿经验，提升MI经验值，获取更多积分

Baidu
Baidu
map
Baidu
map
Baidu
map